Moreover, we revealed that Tmem119 might be a crucial molecule in the heterotopic ossification of muscle in FOP due to the inducion of BMP-2 levels and interaction with the BMP signaling pathway [5] . However, the details of the heterotopic ossification of muscle in FOP remain to be fully elucidated.
BMP-2 plays important roles in bone formation and bone cell differentiation [6] [7] [8] . BMPs act through a complex of type I and type II transmembrane serine/threonine kinase receptors. The ligand bound type II receptor phosphorylates the type I receptor, which activates Smad1/5/8. Activated Smad1/5/8 molecules form a complex with the common Smad, Smad4. The complex translocates to the nucleus and regulates transcription of genes important for controlling the induction of bone formation.
Matrix metalloproteinases (MMPs) are members of a family of zinc-dependent proteinases, which are able to cleave many non-extracellular matrix and extracellular matrix (ECM) components, such as collagens and proteoglycans, and they have a role in normal development and tissue damage in various pathophysiolog-
Cell culture
Mouse myoblastic C2C12 (ATCC) cells were cultured in Dulbecco's modified Eagle's medium (Wako Pure Chem. Osaka, Japan) with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin (Wako Pure Chem.). The medium was changed twice a week, as previously described [19] .
Protein extraction and Western blot analysis
Cells were lysed with Laemmli Sample Buffer (BioRad Laboratories, Inc.) and heated at 100°C for 5 minutes. The same amount of protein aliquots were separated on 10% polyacrylamide-SDS gels. The proteins were transferred to a PVDF membrane in 25 mM Tris, 192 mM glycine, and 20% methanol to polyvinylidene difluoride. Blots were blocked with 20 mM Tris-HCl (pH 7.5), 137 mM NaCl, 0.1% Tween 20, and 3% dried milk powder. The membranes were immunoblotted with each primary antibody. The immune complexes were visualized using the appropriate secondary antibody and the ECL advance detection system (GE Healthcare, Tokyo, Japan), according to the manufacturer's instructions. The results depicted in each figure are representative of at least three independent cell preparations.
RNA extraction and real-time PCR
Total RNA was prepared from cells using TRIzol reagent. Reverse transcription was performed using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster, CA, USA). Quantitative real-time PCR was assessed by the incorporation of SYBR Green into double-stranded DNA and performed on an ABI StepOne Real-Time PCR System (Applied Biosystems). The mRNA value for each gene was normalized relative to the mouse GAPDH mRNA levels in RNA samples. Primer sequence (forward and reverse) were as follows: GAPDH, 5'-GTGTAC ATGGTTCCAGTATGAGTCC-3' and 5'-AGTGAGT TGTCATATTTCTCGTGGT-3'; osteocalcin (OCN), 5'-CCTGAGTCTGACAAAGCCTTCA-3' and 5'-GC CGGAGTCTGTTCACTACCTT-3'; Runx2, 5'-AAAT GCCTCCGCTGTTATGAA-3' and 5'-GCTCCGGC CCACAAATCT-3'; alkaline phosphatase (ALP), 5'-ATCTTTGGTCTGGCTCCCATG-3' and 5'-TTTCCC GTTCACCGTCCAC-3'; Osterix, 5'-AGCGACCACT TGAGCAAACAT-3' and 5'-GCGGCTGATTGGCTTC TTCT-3'; Type I collagen (Col1), 5'-ATGCCTGG TGAACGTGGT-3' and 5'-AGGAGAGCCATCAGCA CCT-3'; MMP-10, 5'-GAGCCACTAGCCATCCTGGical conditions involving wound healing and tissue remodeling [9] . MMPs are classified into subgroups, including collagenases, stromelysins, gelatinases and membrane type MMPs [10] . MMP-10, also called as stromelysin-2, initially identified in a human adenocarcinoma cDNA library, is demonstrated to be expressed in osteoblasts at sites of bone formation as well as in chondrocytes of the growth plate in neonatal ribs in human [11] . Inflammatory cytokine, such as interleukin-β, activates MMP-3 and MMP-10, and these MMPs are considered to expand the degradative potential of cancer cells by targeting no-collagen matrix proteins such as fibronectin and laminin as well as activating latent MMP-1 [12, 13] . Moreover, MMP-10 is enhanced in patients with atherosclerosis and in pathological conditions with increased thrombin generation [14, 15] . Orbe et al. suggested that MMP-10 can enhance tissue plasminogen activatorinduced fibrinolysis via a thrombin-activatable fibrinolysis inhibitor inactivation-mediated mechanism [16] , and we recently reported that plasminogen has a crucial role in bone repair process in mice [17] . In addition, plasminogen activator inhibitor-1 is involved in diabetic bone loss in female mice [18] . However, the role of MMP-10 in osteoblast biology and differentiation has not been reported yet.
We previously performed a comparative DNA microarray analysis between empty vector-transfected and ALK2 (R206H)-transfected mouse myoblastic C2C12 cells [5] . In that study, MMP-10 was estracted as a factor, whose expression was most extensively enhanced by ALK2 (R206H) transfection. In the present study, we therefore investigated the role of MMP-10 in the differentiation of myoblastic cells into osteoblasts.
Materials and Methods

Materials
Human recombinant BMP-2 was purchased from by Sigma-Aldrich Corp (St. Louis, MO, USA). Antiphosphorylated Smad1/5/8 and anti-β-actin antibodies were from Cell Signaling Technology (Danvers, MA, USA). Anti-Smad1, anti-Smad5 and anti-MMP-10 antibodies, MMP-10 siRNA(m) and control siRNA were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Human recombinant MMP-10 protein was from Abnova (Taipei, Taiwan). All other chemicals used were of analytical grade. 
Small interfering (si) RNA
Mouse MMP-10 siRNA and control siRNA were transfected as recommended by the supplier (Sant Cruz) into cells seeded at 5×10 5 cells per well using lipofectamine TM RNAi MAX (invitrogen), as previously described [19] .
ALP activity assay
Cells were seeded in a 6-well plate (2.0 × 10 4 cells/ well) and cultured in DMEM with or without MMP-10 for 48h, then collected with distilled water. ALP activity was measured with LabAssay ALP (Wako Pure Chem.) followed the manufacturer's instructions, as previously described [18] .
Mineralization
Mineralization of C2C12 cells was determined in 6-well plates using Alizarin Red staining. After confluent cells were grown in DMEM supplemented with 10% FBS, 1% penicillin-streptomycin, and 10 mM of β-glycerophosphate for 3 weeks, cells were fixed with ice-cold 70% ethanol and stained with Alizarin Red (Sigma) to detect calcification. For quantitation, cells stained with Alizarin Red were destained with ethylpyridinium chloride (Wako Pure Chem.), the extracted stain was transferred to a 96-well plate, and absorbance at 562 nm was measured using a microplate reader as previously described [19] .
Preparation of primary osteoblasts
Calvarial osteoblastic cells were obtained from C57BL6 mice according to the method described previously [17, 18] . Briefly, calvaria was removed from 3-day-old mice, cleaned of soft tissue, and digested 4 times with 1 mg/mL type IV collagenase and 0.25% trypsin for 20 min at 37°C with gentle agitation. Cells from the second, third, and fourth digestions were plated and grown in α-MEM with 10% fetal bovine serum (FBS). The cells were seeded in a 6-well plate (1.0 × 10 5 cells/well) and grown until confluent.
Statistics
All experiments were repeated at least three times.
Data are expressed as mean ± SEM. Statistical analysis was performed using ANOVA. P value < 0.05 was taken to indicate a significant difference.
Results
Induction of MMP-10 by ALK2(R206H) transfection
In our previous study, C2C12 cell clones stably expressing either empty vector or the ALK2 (R206H) construct, the most frequent ALK2 mutation in FOP patients, were prepared, and the comprehensive DNA microarray analysis between empty vector-and ALK2 (R206H)-expressed C2C12 cells was performed. From approximately 45,000 genes on the Affymetrix gene chip, we identified genes whose expression was increased at least 2 times in the experimental versus the control group (Supplemental Table 1 ). Of all these 40 genes, MMP-10 was a gene, whose expression was mostly marked (8.6 times) in the stable ALK2 (R206H)-transfected C2C12 cells, compared to empty vector-transfected cells [5] . The expressions of Osterix, ALP, Runx2, Col1a1 and Col1a2 were increased by 1.23, 2.00, 1.52, 0.13 and 0.54 times in the stable ALK2 (R206H)-transfected C2C12 cells, compared to empty vector-transfected cells. As shown in Fig.1 , we confirmed marked higher levels in MMP-10 mRNA of stable ALK2 (R206H)-transfected C2C12 cells, compared to empty vector-transfected cells.
Role of MMP-10 in BMP-2 induced-differentiation of myoblasts into osteoblasts
We examined the effects of MMP-10 on the differentiation of myoblasts into osteoblasts induced by in these cells (Fig. 2B) . Meanwhile, MMP-10 did not affect the levels of Runx2, an early osteoblast differentiation marker, enhanced by BMP-2 ( Fig. 2B ). As shown in Fig. 2C and 2D, MMP-10 enhanced mineralization induced by BMP-2, although it did not affect it in the absence of exogenous BMP-2 addition. As shown in Fig. 3A and 3B, the effects of MMP-10 was observed at the concentration of 1 ng/mL and more, and the time course study revealed that MMP-10 effects were observed at 48 hr, but not within 24 hr.
BMP-2. Human recombinant MMP-10 did not affect the levels of osteogenic marker gene mRNA, such as Runx2, Osterix, Col1, ALP and OCN of C2C12 cells in the absence of exogenous BMP-2 ( Fig. 2A) . Moreover, it did not affect ALP activity in these cells in the absence of exogenous BMP-2 (Fig. 2B) . On the other hand, MMP-10 significantly augmented the expressions of Osterix, Col1, ALP and OCN mRNA enhanced by BMP-2 in C2C12 cells ( Fig. 2A) . Moreover, it significantly augmented ALP activity enhanced by BMP-2 nous MMP-10 levels by siRNA significantly decreased the levels of Runx2, Osterix, Col1, ALP and OCN mRNA enhanced by BMP-2 in C2C12 cells (Fig. 4) .
Effects of MMP-10 on the phosphorylation of Smads and BMP-induced genes
We examined the phosphorylation of Smad1/5/8 and the levels of Smad6 and Smad7 in C2C12 cells. As shown in Fig. 5A , MMP-10 increased the phosphorylation of Smad1/5/8 in C2C12 cells. Moreover,
We assume that the level of MMP-10 exogenously added was pharmacological, but not physiological. Because serum levels of MMP-10 in human seemed to be less than 0.5 ng/mL, as previously reported [20] .
Role of endogenous MMP-10 in BMP-2-induced differentiation of myoblasts into osteoblasts
Next, we explored the effects of a reduction in endogenous MMP-10 levels by siRNA on the differentiation of myoblasts into osteoblasts. A reduction in endoge- explore some additional factors that contribute to the ossification of muscle, as previously described [5] . We then identified several factors whose expression is increased by the constitutively active ALK2 (R206H) expression, including MMP-10, NMB (Gpnmb), Frizzled-3 and Tmem119. Transmembrane glycoprotein NMB (Gpnmb), also known as osteoactivin, is a type I transmembrane glycoprotein that is found at the cell surface and lysosomal membranes. It is highly expressed in bone and is related to the regulation of osteoblast maturation [21] . Fzd3 is related to Wnt/ Frizzled signaling through several pathways, including the canonical Wnt/β-catenin and Wnt/Ca2+ pathways [22] . Tmem119 promotes the differentiation of myoblasts into osteoblasts by inducing BMP-2 levels and interacting with the BMP signaling pathway [5, 23] . Among them, MMP-10 was the gene, whose expression was most extensively enhanced by ALK2 (R206H) expression in C2C12 cells, as confirmed in the present study. We have therefore tried to characterize the role of MMP-10 in the differentiation of myoblastic cells into osteoblastic cells. The previous observations in humans with spontaneous mutations and in mice with targeted mutations in MMP genes provide evidence that MMPs have several roles in skeletal development and remodeling. NAO syndromes (nodulosis, arthropathy, osteolysis) characterized by multicentric osteolysis are due to mutations in MMP-2, which result in the absence of detectable serum MMP-2 activity in affected subjects [24] . Later, the phenotype of short snouts, hypertelorism and domeshaped skulls similar to patients with NAO syndromes recurred in Mmp2-null mice [25] . DNA sequence analysis of the SEMD MO , one subform of spondyloepimetaphyseal dysplasias (SEMDs) with moderate to severe metaphyseal changes, mild epiphyseal involvement, pearshaped vertebrae in childhood, rhizomelic shortening especially of the lower limbs and genu varum deformities, revealed a missense mutation in the proregion domain of MMP-13 [26] . Moreover, growth plate abnormalities had just been identified as a major phenotype of Mmp13-null mice [27] . The hypertrophic zones of long bones were increased in Mmp9-/-mice [28]. Mt1-mmp null mice developed a severe skeletal phenotype that included cranial abnormalities such as short snout, orbital protrusions, hypertelorism and dome-shaped skull. Ossification of calvarial bones was delayed and suture closure was never completed [29] . As for MMP-10 and bone, the previous studies MMP-10 enhanced the levels of Smad6 and Smad7 mRNA induced by BMP-2 (Fig. 5B) .
Effects of MMP-10 on myotube differentiation
Finally, we examined the effect of MMP-10 on the differentiation of myoblasts into myotubes. The levels of MyoD, an early myogenic differentiation gene, and myogenin mRNA were similar between with or without 1 ng/mL MMP-10 before the addition of horse serum to induce myotube differentiation (data not shown). As shown in Fig. 6 , MMP-10 significantly decreased the levels of myogenin mRNA induced by horse serum, although its reduction on MyoD mRNA induced by horse serum was not significant, indicating that MMP-10 suppresses the differentiation of myoblasts into myotubes.
Discussion
The previous studies showed that ALK2 (R206H) constitutively activates BMP signaling through Smad1/5/8, thereby contributing to the ectopic bone formation in FOP, a disease characterized by marked heterotopic ossification in muscle tissues [1] [2] [3] [4] . We therefore performed a comparative DNA microarray analysis between empty vector-and ALK2 (R206H)-stably transfected mouse myoblastic C2C12 cells to anism of MMP-10 effects on the differentiation of myoblastic cells into osteoblasts. MMP-10 effects might not be due to its direct effects on BMP-Smad pathway, because its effects on the differentiation of myoblastic cells took more than 24 hr and many matrix proteins are included in the substrates for MMP-10. For example, fibronectin, one of substrates of MMP-10, modulates osteoblast function [37] . MMP-10 might affect BMPinduced differentiation of myoblasts into osteoblasts through the release of bone matrix proteins induced by MMP-10. Further studies will be necessary to clarify the precise mechanism underlying these phenomena. The mechanisms by which ALK2(R206H) transfection induces MMP-10 levels in C2C12 cells are still unknown in the present study. BMP family proteins, including BMP-2, 4, 6 and 7, affect cells through ALK2, and the ALK2 (R206H) mutation mildly activates BMP signaling, as previously reported [4] . Although the most crucial ligand of ALK2 for the pathogenesis of FOP have not been determined yet, our preliminary study revealed that exogenous BMP-2 addition did not induce the levels of MMP-10 mRNA in C2C12 cells (data not shown). Therefore, the ligands other than BMP-2 may be responsible for the induction of MMP-10 by an activation of ALK2 signaling.
In conclusion, MMP-10 was identified as a molecule whose expression was increased in myoblastic cells overexpressing the constitutively activating ALK2 mutation responsible for FOP. The present study first demonstrated that MMP-10 promotes the differentiation of myoblasts into osteoblasts by interacting with the BMP signaling pathway. MMP-10 may play some important role in the heterotopic ossification of muscle in FOP, and the further studies of the mechanisms whereby it acts may lead to understanding for the pathogenesis of muscle ossification as well as the development of novel treatments for FOP and other-related mineralization disorders.
indicated that MMP-10 is expressed in osteoblasts as well as chondrocytes, but not in osteocytes, although the controversy exists about its expression in osteoclasts [11, 30] . MMP-10 has broad substrate specificity including proteoglycans, laminin and fibronectin [31] . The present study revealed that MMP-10 augmented the differentiation of myoblastic cells into osteoblastic cells induced by BMP-2, although it did not possess the activity of osteoinduction in the absence of exogenous BMPs. Moreover, a reduction of endogenous MMP-10 levels by siRNA significantly suppressed the levels of osteogenic marker mRNA enhanced by BMP-2 in myoblastic cells. On the other hand, our preliminary study suggested that MMP-10 had little effects on ostegenic marker expression in mouse primary osteoblast cultures in the absence of exogenous BMP-2 (data not shown). These findings suggest that MMP-10 might play some role in the pathogenesis of muscle ossification in FOP, although it does not seem to be critical for osteoblastic bone formation physiologically.
Osteoblast, chondrocytes, adipocytes and myotubes are derived from common precursors, multipotential mesenchymal stem cells derived from mesoderm [32] . Several osteotropic factors differentially regulate the commitment of the multipotential stem cells into various cell lineages [33, 34] . BMPs are necessary for different steps of chondrogenesis, chondroprogenitor determination and/or condensation and subsequent differentiation into chondrocytes [35] . Moreover, BMPs inhibit myoblast differentiation by inducing the basic helixloophelix protein, hair enhancer-of-split-related 1(HesR1), which transcriptionally represses myogenesis by forming an inactive complex with MyoD [36] . In the present study, MMP-10 alone did not affect the expression of osteoblast differentiation markers and ALP activity in myoblasts, although it augmented the differentiation of myoblasts into osteoblasts enhanced by BMP-2. These findings suggest that MMP-10 is not the central molecule for the pathogenesis of muscle ossification in FOP in contrast to BMPs, although it might play some role in BMP pathways. In present study, MMP-10 enhanced the phosphorylation of Smad1/5/8 in mouse myoblastic cells. Moreover, MMP-10 enhanced the levels of Smad6 and Smad7 mRNA, BMP-signal-responsive genes, induced by BMP-2 in these cells. These findings suggest that MMP-10 regulates BMP signaling pathway. In the present study, we could not clarify the precise mech- 
